Donate
T1International Statement on COVID-19

T1International Statement on COVID-19

Facebook Google LinkedIn Twitter

As the world grapples with the effects of a global pandemic, the situation is evolving quickly and the short and long-term impacts are still unclear. What is clear is that the COVID-19 crisis stresses the need to approach healthcare as a human right. The crisis also emphasizes the need for international cooperation to fix global health problems. There must be solidarity in the fight for #insulin4all and universal access to healthcare.

When Frederick Banting discovered insulin in 1922, he said of his discovery, “Insulin does not belong to me, it belongs to the world.” Similarly, in 1955, when Jonas Salk was interviewed about the vaccine he developed for polio, he was asked who owned the patent, to which he responded, “Well, the people, I would say.” Banting and Salk put the good of the world above any desire for profit. It is imperative that once a vaccine is found for COVID-19, we follow in the footsteps of Banting and Salk, so that everyone in the world is able to access the vaccine for free. It is unconscionable that this is even in question.

Too many patients around the globe receive substandard care, and it is frightening that already strapped health systems will be further strained by this crisis. Until a vaccine is found, it is crucial that testing and treatment for COVID-19 be thorough, equitable, and affordable, regardless of income, insurance status, or location.

Governments must put the health of humankind first, and they should work to ensure that no one suffers unduly for making often difficult choices to protect themselves and others by preventing the spread of the illness. This particularly applies to the most vulnerable, who have been marginalized in their communities prior to the coronavirus.

It is also essential that the language about and support provided to vulnerable people - including those who are older, immunocompromised, and in humanitarian crisis settings or displaced for any reason - is altered. Those with health conditions or disabilities, the elderly, and the poor are not disposable, as the media and public rhetoric often seem to imply. People with diabetes, along with others, have been shouting about the inadequate healthcare around the world for a long time. Now that this global epidemic is a reality, more people will suffer and die because of profit-driven and under-resourced health systems.

We hope that this situation, while scary and challenging, will show how strong humanity can be, and how coming together will always make us stronger. We are a community, and in this time of uncertainty, it’s more important than ever for us to join together and care for one another.


Support and Guidance:

Related posts:

T1International Statement on Brexit

T1International Statement on Brexit

We stand ready to hold the UK government to account on the provision of healthcare for UK citizens with type 1 diabetes over the coming months and years. We will strongly resist any erosion of the current provision of essential medicine and supplies, medical devices or support services for patients with type 1 diabetes in the UK. Read more

T1International Statement on Lilly & Novo's ''Generic Insulin''

T1International Statement on Lilly & Novo's ''Generic Insulin''

Patient-led activism is working. Today Eli Lilly announced that in response to criticism of high prices, the company will sell a version of Humalog insulin for half price. We are pleased to see this result after continual and dedicated efforts by non-pharma funded patient advocates to ensure list price of insulin goes down. While half-price is an improvement, it's still an unaffordable price for so many, considering most people need at least 2 vials each month.
Read more

T1International Statement on Novo Nordisk and Sanofi Price Hikes

T1International Statement on Novo Nordisk and Sanofi Price Hikes

Sanofi and Novo Nordisk are celebrating the New Year with fresh price hikes on their decades-old insulin products. “Sanofi increased the price of its three main insulin brands by between 4.4 %- 5.2 % last week, while Novo Nordisk increased the price of its insulin products by just under 5% on Tuesday,” the Financial Times article said. Once again, shareholder profits will be increased on the backs of people with diabetes. Read more

Nicole Smith-Holt Statement on Eli Lilly Helpline Announcement

Nicole Smith-Holt Statement on Eli Lilly Helpline Announcement

I vow to continue to fight for the rights and lives of all people with diabetes. I am doing all this in honor of my son, Alec Raeshawn Smith. I invite Lilly to work with me and non-industry funded organizations like T1International so that we can find real solutions to ensure #insulin4all. Mr. Mason, I am still waiting to hear from you. Read more

T1International Statement on #insulin4all for Civil Society Hearing on NCDs

T1International Statement on #insulin4all for Civil Society Hearing on NCDs

The high price of life-saving medications, including the rising prices of insulin, are killing people living with NCDs worldwide. Families are being financially ruined here in the United States, and around the world. This reality is not complicated to understand but it is impossible for us to live with. Read more

T1International Statement on Walmart Insulin

T1International Statement on Walmart Insulin

Recently, the American Diabetes Association issued a white paper on Insulin Access and Affordability by their Working Group. While we continue to applaud the American Diabetes Association for speaking out about the high cost of insulin, we remain concerned with their approach and some of the recommendations in their paper.
Read more

T1International Statement on ADA Insulin Price Petition

T1International Statement on ADA Insulin Price Petition

It is fantastic to see a large diabetes organization speaking out in this way. However, we feel that the ADA’s language around the call for price transparency does not go far enough. Read more